pharmaceuticals
Pharma presses for higher drug prices in Europe, including Switzerland
Pharmaceutical companies are pressing for higher medicine prices and broader reforms in Europe, including Switzerland, despite expectations that US President Donald Trump’s pricing policy will have less impact than first anticipated. The debate could affect drug costs and the incentives companies cite for developing new medicines.
about 2 hours ago · 1 source
